The integrin αvβ3 is a receptor for the latency-associated peptides of transforming growth factors β1 and β3

Biochemical Journal

Volumn 369, Issue 2, 2003, Pages 311-318

  Ludbrook, Steven B ^a   Barry, Simon T ^a,b   Delves, Chris J ^a   Horgan, Carmel M T ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Adhesion; Binding; Cell; Fibronectin; Vitronectin

Indexed keywords

FLAMMABILITY; MOLECULES; POSITIVE IONS; PROTEINS;

LATENCY-ASSOCIATED PEPTIDES;

BIOCHEMISTRY;

GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; INTEGRIN; INTEGRIN RECEPTOR; LIGAND; PEPTIDE; PROTEIN INHIBITOR; SB 223245; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG; ACETIC ACID DERIVATIVE; ANTINEOPLASTIC AGENT; ARGINYL-GLYCYL-ASPARTIC ACID; ARGINYLGLYCYLASPARTIC ACID; BENZODIAZEPINE DERIVATIVE; BETA INTEGRIN; BETA5 INTEGRIN; BETA6 INTEGRIN; OLIGOPEPTIDE; PEPTIDE FRAGMENT; PROTEIN PRECURSOR; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA; VITRONECTIN RECEPTOR;

ARTICLE; BINDING AFFINITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; FIBROSIS; HUMAN; HUMAN CELL; INFLAMMATION; LATENT PERIOD; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MOTIF; ANIMAL; BINDING SITE; CELL ADHESION; CELL STRAIN K 562; DRUG ANTAGONISM; GENETICS; METABOLISM; PROTEIN SECONDARY STRUCTURE;

ACETIC ACIDS; ANIMALS; ANTINEOPLASTIC AGENTS; BENZODIAZEPINONES; BINDING SITES; CELL ADHESION; HUMANS; INTEGRIN ALPHAVBETA3; INTEGRIN BETA CHAINS; K562 CELLS; LIGANDS; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN PRECURSORS; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, VITRONECTIN; RECOMBINANT FUSION PROTEINS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3;

EID: 0037437369     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20020809     Document Type: Article

References (59)

1. Massague, J. (1990) The transforming growth factor β family. Annu. Rev. Cell Biol. 6, 597-641
2. Blobe, G. C., Schiemann, W. P. and Lodish, H. F. (2000) Role of transforming growth factor βin human disease. N. Engl. J. Med. 342, 1350-1358
3. Piek, E., Heldin, C. H. and Ten Dijke, P. (1999) Specificity, diversity, and regulation in TGF-β superfamily signaling. FASEB J. 13, 2105-2124
4. Massagué, J., Blain, S. W. and Lo, R. S. (2000) TGFβ signaling in growth control. cancer, and heritable disorders. Cell 103, 295-309
5. 1 by plasmin. J. Cell Biol. 110, 1361-1367
6. Sato, Y., Tsuboi, R., Moses, H. and Rifkin, D. B. (1990) Characterization of the activation of latent TGF-β by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J. Cell Biol. 111, 757-763
7. Nunes, I., Shapiro, R. L. and Rifkin, D. B. (1995) Characterization of latent TGF-β activation by murine peritoneal macrophages. J. Immunol. 155, 1450-1459
8. 1 in human seminal plasma. Biochem Biophys. Res. Commun. 253, 128-134
9. Yu, Q. and Stamenkovic, I. (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev 14, 163-175
10. Lyons, R. M., Keski-Oja, J. and Moses, H. L. (1988) Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium. J. Cell. Biol. 106, 1659-1665
11. Schultz-Cherry, S. and Murphy-Ullrich, J. E. (1993) Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism. J. Cell Biol. 122, 923-932
12. Schultz-Cherry, S., Chen, H., Mosher, D. F., Misenheimer, T. M., Krutzsch, H. C., Roberts, D. D. and Murphy-Ullrich, J. E. (1995) Regulation of transforming growth factor-β activation by discrete sequences of thrombospondin 1. J. Biol. Chem. 270, 7304-7310
13. Ribeiro, S. M., Poczatek, M., Schultz-Cherry, S, Villain, M. and Murphy-Ullrich, J. E. (1999) The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-β. J. Biol. Chem 274, 13585-13593
14. 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96, 319-328
15. 1. Mol. Biol Celll., 2527-2638
16. 1. J. Cell Biol. 157, 493-507
17. 1 in vivo. Cell 03, 1159-1170
18. 6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin. J. Cell. Biol. 133, 921-928
19. 6 knockout mice. Am. J. Respir. Cell Mol. Biol. 19, 636-642
20. 3) antagonists. J. Med. Chem. 40, 2289-2292
21. 1 that inhibit allergic airway responses. J. Med. Chem. 42, 920-934
22. 6 integrin. J. Biol. Chem. 274, 1979-1985
23. Yatohgo, T., Izumi, M., Kashiwagi, H. and Hayashi, M. (1988) Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct. Funct. 13, 281-292
24. Bittorf, S. V., Williams, E. C. and Mosher, D. F. (1993) Alteration of vitronectin. Characterization of changes induced by treatment with urea. J. Biol. Chem. 268, 24838-24846
25. Marshall, J. F., Nesbitt, S. A., Helfrich, M. H., Horton, M. A., Polakova, K. and Hart, I. R. (1991) Integrin expression in human melanoma cell lines: heterogeneity of vitronectin receptor composition and function. Int. J. Cancer 49, 924-931
26. 1 integrin and osteopontin. Biochem. Biophys. Res. Commun. 267, 764-769
27. 6 on cell proliferative responses to tenascin. Roles of the β subunit extracellular and cytoplasmic domains. J. Biol. Chem. 271, 24144-24150
28. 1 function. J. Cell Biol. 145, 889-897
29. Cheresh, D. A. (1987) Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc. Natl. Acad. Sci. U.S.A. 84, 6471-6475
30. 3. J. Biol. Chem. 275, 16891-16898
31. 3 integrin "vitronectin receptor". Int. J. Biochem. Cell Biol. 29, 721-725
32. 3)-ligand interaction. Identification of a heterodimeric RGD binding site on the vitronectin receptor. J. Biol. Chem. 265, 2168-2172
33. Kieffer, N., Fitzgerald, L. A., Wolf, D., Cheresh, D. A. and Phillips, D. R. (1991) Adhesive properties of the β 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells. J. Cell Biol. 113, 451-461
34. 1 in promoting cellular attachment and spreading on fibronectin. J. Cell Biol. 111, 2795-2800
35. 3 integrin stimulates immediate cell signals in osteoclasts. J. Biol. Chem. 266 20369-20374
36. Felding-Habermann, B., Silletti, S., Mei, F., Siu, C. H., Yip, P. M., Brooks, P. C., Cheresh, D. A., O'Toole, T. E., Ginsberg, M. H. and Montgomery, A. M. (1997) A single immunoglobulin-like domain of the human neural cell adhesion molecule L1 supports adhesion by multiple vascular and platelet integrins. J. Cell Biol. 139, 1567-1581
37. 3. J. Biol. Chem. 273, 3090-3096
38. 3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol. Cell. Biol. 19, 2958-2966
39. 3. J. Biol. Chem. 270, 9917-9925
40. 3 subunit. J. Biol. Chem. 277, 11126-11134
41. Gehlsen, K. R., Davis, G. E. and Sriramarao, P. (1992) Integrin expression in human melanoma cells with differing invasive and metastatic properties. Clin. Exp. Metastasis 10, 111-120
42. 5 integrins by human lung carcinoma cells of different histotypes. Exp. Cell Res. 216, 113-122
43. 3-mediated endocytosis of immobilized fibrinogen by A549 lung alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 24, 12-21
44. 3. FEBS Lett. 511, 65-68
45. 1 on endothelial cells. J. Biol. Chem. 272, 5360-5366
46. 3 (the vitronectin receptor). Drug Disc. Today 5, 397-408
47. Ashkar, S., Weber, G. F., Panoutsakopoulou, V., Sanchirico, M. E., Jansson, M., Zawaideh, S., Rittling, S. R., Denhardt, D. T., Glimcher, M. J. and Cantor, H. (2000) Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287, 860-864
48. 3), reduces neointimal hyperplasia and total vessel area after balloon injury in hypercholesterolemic rabbits. Circ. Res. 84, 1268-1276
49. Spirin, K. S., Saghizadeh, M. Lewin, S. L., Zardi, L., Kenney, M. C. and Ljubimov, A. V. (1999) Basement membrane and growth factor gene expression in normal and diabetic human retinas. Curr. Eye Res. 18, 490-499
50. 1 in bronchoalveolar lavage fluid from patients with scleroderma. J. Rheumatol. 22, 1876-1883
51. Lettesjo, H., Nordstrom, E., Strom, H., Nilsson, B., Glinghammar, B., Dahlstedt, L. and Moller, E. (1998) Synovial fluid cytokines in patients with rheumatoid arthritis or other arthritic lesions. Scand. J. Immunol. 48, 286-292
52. 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J. Immunol. 165, 3423-3429
53. Yehualaeshet, T., O'Connor, R., Green-Johnson, J., Mai, S., Silverstein, R., Murphy-Ullrich, J. E. and Khalil, N. (1999) Activation of rat alveolar macrophage-derived latent transforming growth factor β-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. Am. J. Pathol. 155, 841-851
54. 1. Eur. J. Immunol. 29 1004-1013
55. 3. Cell 85, 683-693
56. Schlaepfer, D. D. and Hunter, T. (1998) Integrin signalling and tyrosine phosphorylation: just the FAKs? Trends Cell. Biol. 8, 151-157
57. 3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival J. Clin. Invest. 103, 229-238
58. 3 integrins are osteosclerotic because of dysfunctional osteoclasts. J. Clin. Invest. 105, 433-440
59. v integrins. Cell 95, 507-519